Foundation Consumer Healthcare

What Foundation Consumer Healthcare does

Foundation Consumer Healthcare, LLC is a privately-held over-the-counter (OTC) consumer healthcare company headquartered in Pittsburgh, Pennsylvania, founded in 2014 and backed by private equity firms Kelso & Co. and Juggernaut Capital Partners. The company built and operated a portfolio of 11 differentiated OTC brands spanning emergency contraception (Plan B One-Step), nasal care (Breathe Right, prior to divestiture), cough/cold (Children's Dimetapp), oral care/anesthetics (Anbesol, Campho-Phenique), asthma (Bronkaid, Primatene), allergy (Alavert), sinus (Dristan), fiber therapy (FiberCon), and low-dose aspirin (St. Joseph). Products were sold over-the-counter without prescription at major retailers across all 50 states, with some behind-pharmacy-counter SKUs. Plan B One-Step is the #1 OB/GYN-recommended emergency contraceptive and the only retained brand following the June 2026 divestiture of 10 OTC wellness brands to Prestige Consumer Healthcare for $1.045 billion.

The company makes money through wholesale OTC product sales to retail chains and pharmacies, augmented by an asset-light operating model that outsources manufacturing. Distribution runs through major retail classes of trade nationally, supplemented by a Community Impact Program that donates Plan B tablets to advocacy organizations, health clinics, and college student groups serving contraceptive deserts. Following the strategic repositioning announced in March 2026 and the August 2026 CEO transition (Rupa Bahri succeeding founder Greg Bradley), the company has become a focused pure-play women's health operator anchored by Plan B One-Step, with proceeds from the divestiture available to fund further women's health expansion.

The technology and platform layer is pharmaceutical-grade formulation and FDA-regulated OTC product registration rather than software or AI. Plan B One-Step's core technology is a 1.5 mg levonorgestrel tablet that temporarily delays ovulation when taken within 72 hours of unprotected sex or contraceptive failure; the FDA approved a corrected label in December 2022 to clarify the mechanism. Leadership brings substantial OTC-switch experience (former GSK, Novartis, Haleon, McKinsey executives) and supply chain depth (former GSK North America Head of Customer Supply Chain), underwriting the company's ability to integrate additional women's health brands into the existing national retailer footprint.

Name

Foundation Consumer Healthcare

Legal name

Foundation Consumer Healthcare, LLC

Website

https://foundationch.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Foundation Consumer Healthcare is a privately-held OTC consumer healthcare company that, following the June 2026 divestiture of its wellness brands to Prestige Consumer Healthcare for $1.045 billion, operates as a pure-play women's health business anchored by Plan B One-Step, the #1 OB/GYN-recommended emergency contraceptive sold OTC across all 50 U.S. states.

Ownership category

akta.pro rank

Product category

Over-the-Counter Consumer Healthcare

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Women’s Health (OTC Gynecologic) (HLAIADAJ)

akta.pro secondary industry

Feminine & Sexual Wellness OTC (Yeast Infection OTC, Lubricants, Condoms, Pregnancy Tests) (CRADAMAH)

Keywords

• Over-the-counter healthcare
• Consumer health products
• Emergency contraception
• OTC pharmaceuticals
• Women's health products

Headquarters

HQ city

Pittsburgh

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D

Revenue model

1. OTC Consumer Healthcare Product Sales: Foundation Consumer Healthcare generates revenue through the sale of over-the-counter consumer health and wellness products, including emergency contraception, nasal strips, cold/flu remedies, and other OTC healthcare brands sold through major retail channels across all 50 states.
2. Breathe Right and OTC Brand Portfolio: The company sold its Breathe Right brand and 9 other OTC brands to Prestige Consumer Healthcare for $1.045 billion in June 2026. The portfolio generated approximately $200 million in revenue and $95 million in EBITDA over the twelve months ended December 31, 2025.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Foundation Consumer Healthcare develops and sells over-the-counter (OTC) consumer healthcare products in the United States. Following a 2026 strategic repositioning, the company focuses exclusively on its Women's Health business anchored by Plan B One-Step, an FDA-approved emergency contraception tablet. The company previously operated a broader portfolio of OTC brands (Breathe Right, Dimetapp, Anbesol, etc.) that were divested to Prestige Consumer Healthcare for $1.045 billion.

Product overview

Foundation Consumer Healthcare is the #1 privately-held OTC healthcare manufacturer in the United States, dedicated to improving consumers' lives through differentiated over-the-counter products. The company operated a portfolio of 11 consumer-trusted brands including Plan B One-Step® (the flagship women's health/emergency contraception product and #1 OB/GYN-recommended brand) and various wellness brands (Breathe Right®, Children's Dimetapp®, Anbesol®, Campho-Phenique®, St. Joseph® Low Dose Aspirin, Bronkaid®, Primatene®, FiberCon®, Alavert®, and Dristan®). Following a strategic repositioning, the company divested its OTC wellness brands to Prestige Consumer Healthcare in June 2026 and now focuses exclusively on its Women's Health business anchored by Plan B One-Step®.

Differentiator

Problem solved

Functional benefit

Brands

• Plan B One-Step®: The #1 OB/GYN-recommended OTC emergency contraceptive brand that helps prevent pregnancy when taken within 72 hours after unprotected sex or birth control failure.
• Breathe Right® Nasal Strips
• Children's Dimetapp®
• Anbesol®
• Campho-Phenique®
• St. Joseph® Low Dose Aspirin
• Bronkaid®
• Primatene® Tablets
• FiberCon®
• Alavert
• Dristan®

Products and services

• Plan B One-Step® Emergency contraception containing 1.5 mg levonorgestrel that helps prevent pregnancy by temporarily delaying ovulation when taken within 72 hours after unprotected sex or birth control failure. Available over-the-counter without prescription or ID in all 50 U.S. states. The #1 OB/GYN-recommended OTC emergency contraceptive brand and the company's flagship retained product following the June 2026 portfolio divestiture.

Quantifiable outcome

• Over 700,000 Plan B tablets donated to 1,200+ organizations across all 50 states
• +3 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Five partnerships are on record, tiered major, core and minor.

• Prestige Consumer Healthcare Inc.majorStrategic or Co-development Partner · 15 June 2026Prestige Consumer Healthcare acquired Breathe Right and 9 other OTC brands from Foundation Consumer Healthcare for $1.045 billion in June 2026. The deal brings approximately $200 million in annual revenue and $95 million in EBITDA. Foundation retained its Women's Health business. Both companies have aligned business models around outsourced manufacturing and overlapping customer bases.
• Advocacy OrganizationscoreGTM or Marketing Partner · 22 October 2024Foundation Consumer Healthcare partners with advocacy organizations through its Community Impact Program, donating Plan B tablets for free distribution to underserved communities and contraceptive deserts across all 50 states. Over 700,000 tablets donated to more than 1,200 organizations.
• Zeno GroupminorOthers · 22 October 2024Zeno Group is the PR agency representing Foundation Consumer Healthcare, handling media inquiries and communications on behalf of the company.
• Health ClinicscoreGTM or Marketing Partner · 20 September 2023Health clinics across 48 states and Washington D.C. receive donations of Plan B emergency contraception through the Community Impact Program to distribute to women in underserved communities with limited access to healthcare products.
• College Student GroupsminorGTM or Marketing Partner · 20 September 2023College student groups partner with Foundation Consumer Healthcare to receive Plan B donations for distribution to their communities, supporting women's access to emergency contraception on college campuses.

Scale indicators8 records

Recent moves7 records

Expansion highlights4 records

Market position

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/foundation-consumer-healthcare

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Foundation Consumer Healthcare